Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
18 NC counties are under alert.
Program
On WRAL at 6: WRAL Investigates claims of life-changing mistakes and the apparent lack of oversight for doctors
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Single/session
Recent news which mentions Single/session
Latest research shows Australians still not getting annual skin checks with a Health Professional
March 01, 2023
Tags
Basal Cell Carcinoma
Painless
Rhenium/188
From
PRLog
London skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
September 27, 2022
Tags
Health
Rhenium/SCT
Germany
From
PRLog
Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT
April 13, 2022
Tags
Rhenium/SCT
Science
Germany
From
PRLog
OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia
December 21, 2021
Tags
Rhenium/188
Painless
Basal Cell Carcinoma
From
PRLog
South African non-melanoma skin cancer patients now have greater access in the area of Johannesburg to innovative non-invasive treatment Rhenium-SCT®
November 16, 2021
Tags
Rhenium/188
Painless
Basal Cell Carcinoma
From
PRLog
OncoBeta initiates international EPIC-Skin study with Rhenium-SCT® for the treatment of Skin Cancer
September 09, 2021
Tags
Skin Cancer Therapy
Medical
Germany
From
PRLog
Australian Nuclear Science and Technology Organization (ANSTO), the new production partner of OncoBeta® GmbH in Australia
July 13, 2021
Tags
Squamous Cell Carcinoma
Rhenium/188
Basal Cell Carcinoma
From
PRLog
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.